Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion type Assertion NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_head.
- NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion description "[Cap43 has potential as a molecular marker to determine the therapeutic efficacy of antiestrogenic anticancer agents in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_provenance.
- NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion evidence source_evidence_literature NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_provenance.
- NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion SIO_000772 16707596 NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_provenance.
- NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion wasDerivedFrom befree-20140225 NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_provenance.
- NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_assertion wasGeneratedBy ECO_0000203 NP307018.RAHBYYFuVd3nyMhIjL5f1TOTk6LwMy2Tntn63Y1UjhTMs130_provenance.